Tzvi Palash

2015

In 2015, Tzvi Palash earned a total compensation of $442K as Chief Operating Officer at Protalix BioTherapeutics, a 8% decrease compared to previous year.

Compensation breakdown

Bonus$60,000
Option Awards$49,141
Salary$208,106
Stock Awards$53,547
Other$71,192
Total$441,986

Palash received $208.1K in salary, accounting for 47% of the total pay in 2015.

Palash also received $60K in bonus, $49.1K in option awards, $53.5K in stock awards and $71.2K in other compensation.

Rankings

In 2015, Tzvi Palash's compensation ranked 11,268th out of 13,638 executives tracked by ExecPay. In other words, Palash earned more than 17.4% of executives.

ClassificationRankingPercentile
All
11,268
out of 13,638
17th
Division
Manufacturing
4,308
out of 5,187
17th
Major group
Chemicals And Allied Products
1,590
out of 1,857
14th
Industry group
Drugs
1,311
out of 1,531
14th
Industry
Biological Products, Except Diagnostic Substances
223
out of 260
14th
Source: SEC filing on March 16, 2017.

Palash's colleagues

We found four more compensation records of executives who worked with Tzvi Palash at Protalix BioTherapeutics in 2015.

2015

Moshe Manor

Protalix BioTherapeutics

Chief Executive Officer

2015

Yossi Maimon

Protalix BioTherapeutics

Chief Financial Officer

2015

Yoseph Shaaltiel

Protalix BioTherapeutics

Executive Vice President, Research and Development

2015

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

You may also like